Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.
Antonopoulos
Stavros
S
Mikros
Sotiris
S
Mylonopoulou
Maria
M
Kokkoris
Stelios
S
Giannoulis
Gregory
G
D005234:Fatty Liver / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005464:Fluorobenzenes / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D011743:Pyrimidines / Q000627:therapeutic use*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium